Browse studies

Find your next paid study

28 recruiting studies matching your filters

Lupus Nexus Landmark Study: A Prospective Registry and Biorepository

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct o…

Systemic Lupus Erythematosus (SLE)Lupus NephritisNeuropsychiatric Systemic Lupus Erythematosus

Estimated

~$10 – $1,125

Lupus Research AllianceNCT05934149

Web-Based Data Collection Through the Research Accelerated by You (RAY) Lupus Registry

Summary The Lupus Foundation of America (LFA) Research Accelerated by You (RAY) Registry is a fully remote, longitudinal registry designed to collect data from…

Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Cutaneous Lupus Erythematosus (CLE)

Estimated

~$10 – $750

Lupus Foundation of AmericaNCT06927219

Phase 1

Safety and Efficacy of ONTO1 in Lupus

ONT01 is a drug that is being studied for the treatment of Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) and is not approved by the FDA. The purp…

Lupus Nephritis (LN)Lupus Nephritis - WHO Class IIILupus Nephritis - WHO Class IV+5 more

Estimated

~$10 – $6,250

Hospital for Special Surgery, New YorkNCT07107659

Phase 1

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

The goal of Safety Lead-In is to confirm the safety of tafasitamab when given to patients with SSc, SLE, and LN. The goal of Phase 1 is to find the recommende…

Autoimmune DisordersSystemic SclerosisSystemic Lupus Erythematosus+2 more

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT06434363